Bek, Barbara

Bogner, Johannes R.

Burkowitz, Jörg

Koch, Judith

Koch, Meinrad A.

Schwartländer, Bernhard

Skarabis, Horst

English

Open Access LMU

A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia.

AL: A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia.

AL: Effect of zidovu· dine and Pneumocystis carinii pneumonia prophylaxis Improved predictive value of CD4 + count Schwartländer et aJ. 821 on progression of HIV-1 infection to AIDS. Lancet

AL: Tbe effect of zidovudine treatment on serum neopterin and ß2-microglobulin levels in mildly symptomatic, HIV type l-seropositive individuals. ] Acquir Immune Defic Syndr

Appearance of predictors of disease progression in relation to the development of AIDS. AIDS

AR: Differences in laboratory values in HIV infection by sex, race, and risk group. AIDS

DISEASE CONTROL: Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. MMW1i'

Elevated serum betaz-microglobulin - a prognostie marker for development of AIDS among patients with persistent generalized lymphadenopathy. Inf ection

ET AL: Immunologie markers of progression to acquired immunodeficiency syndrome are tirne-dependent and illness-specific.

ET AL: Infiuence of zidovudine on progression to AIDS in cohort studies [letter]. Lancet

ET AL: Neopterin: a predictive marker of acquired immune deficiency syndrome in human immunodeficiency virus infection. J Acquir Immune Dejic Syndr

ET AL: Predictors of the risk of acquired immunodeficiency syndrome within 24 months among gay men seropositive for human immunodeficiency virus type 1: areport from the multicenter AIDS cohort study.

Five-year prospective study of HIV infection in the Edinburgh haemophiliac cohort. BM

HEALTH: Recommendations for zidovudine: early infection. JAMA

JL: Serum neopterin in HlV-infected subjects: indicator of sigrLificant pathology, CD4 T-cell changes, and the development of AIDS. J Acquir Immune Dejic Syndr

JM: Immunologieal and serological markers predictive of progression to AIDS in a cohort of HIVinfected drug users. AIDS

KELSTEIN W JR: Use of ßz-mieroglobulin level and CD4 lymphocyte count to predict development of acquired irnmunodeficieney syndrome in persons with human immunodeficiency virus infection. :Arch Intern Med

MH: Effect of azidothymidine (AZT) on HIV p24 antigen, beta2-microglobulin, neopterin, soluble CD8, soluble interleukin-2 receptor and tumor necrosis factor alpha levels in patients with AIDS-related complex or AIDS. IntJ Immunopharmacol

Neopterin and beta2' microglobulin: their relationship with T-Iymphocyte subsets and symptomatological status in HIV infection.

Neopterin as a marker for activated cell-mediated immunity: application in HlV infection. Immunol Today

PAut DA Circulation of HlV antigen in blood according to stage of infection, risk group, age and geographic origin. Epidemiol Inf ect

PAUU G: Zur Bewertbarkeit der Lymphozten-phänotypisierung - Auswertung und Ergebnisse des ersten Berliner Ringversuches. (Assessment of lymphocyte phenotyping - result of the first ring test in Berlin.) Lab Med

PINCHING A CD4 fiuctuates within restrieted regions of the normal range in heterosexual control subjects.

Predictive markers for the acquired immunodeficiency syndrome (AIDS) in hemophiliacs: persistence of p24 antigen and low T4 cell count. Ann Intern Med

Progression to AIDS and predictors of AIDS in seroprevalent and seroincident cohorts of homosexual men.

Seropositivity for HIV and the development of AIDS or AIDS-related con· dition: three-year follow-np of the San Francisco General Hospital eohoet. BM

Serum ß2-microglobulin decreases in patients with AIDS or ARC treated with azidothymidine. ] Infect Dis

Serum ß2-microglobulin level increases in HlV infection: relation to seroconversion, CD4 T-cell fall and prognosis. AIDS

SKIOMORE SJ: Neopterin and betaz-microglobulin levels in asymptomatie HIV infection: the predictive value of combining markers.

SORICE F: Serum ß2M in asymptomatic HIV-infected patients treated with zidovudine [letter]. AIDS

Sources of variability in repeated T-helper lymphocyte counts from human imrnunodeficiency virus type l-infected patients: totallymphocyte count fiuctuations and diurnal cyde are important. J Acquir Immune Dejic Syndr

The prognostie value of cellular and serologic markers in infection with human immunodeficiency syndrome virus type 1.

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. Ann Intern Med

WmELL L: Serum ßz-microglobulin in various disorders. Clin ehem Acta

Zidovudine in asymptomatic human immunodeficiency virus infection.

Improvement of the predictive value of CD4+ lymphocyte count by b2-microglobulin, immunoglobulin A and erythrocyte sedimentation rate

http://epub.ub.uni-muenchen.de/8183/1/improvement_of_the_predictive_value_of_cd4plus_lymphocyte_count_8183.pdf

Improvement of the predictive value of CD4+ lymphocyte count by b2-microglobulin, immunoglobulin A and erythrocyte sedimentation rate

Abstract

Similar works

Full text

Available Versions

Open Access LMU